Back to Federation des caisses Desjardins du Quebec Federation des caisses Desjardins du Quebec

BCTXBCTX
4 quarters

Position history for Federation des caisses Desjardins du QuebecFederation des caisses Desjardins du Quebec's holdings in BRIACELL THERAPEUTICS CORP

Yes. Federation des caisses Desjardins du Quebec holds 450 shares of BCTX (Briacell Therapeutics), worth $1,444, as of its Q2 2026 13F filing. It reduced the position by 5 shares (-1.1%) from Q1 2026. Federation des caisses Desjardins du Quebec has held BCTX since Q3 2025, across 4 quarterly 13F filings.

Current Value

$1,444

Current Shares

450

Total Value Change

-$8,394

Total Shares Change

-455

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
450
-1.1%
$1,4440.0%$3.24
0
2026-Q1
Decreased
455
-62.2%
$1,6630.0%$4.02
0
2025-Q4
Increased
1,205
+33.1%
$8,5660.0%$7.59
15
2025-Q3
New
905
-
$9,8380.0%$10.83
26

Other major holders of BCTX: UBS Group AG, CITADEL ADVISORS LLC, HRT FINANCIAL LP, JANE STREET GROUP, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used